Evidence map›Paper›PMID 26416032›Full record

ReviewVirchows Archiv : an international journal of pathology2016

Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia.

Leticia Quintanilla-Martinez, Birgitta Sander, John K C Chan, Luc Xerri, German Ott, Elias Campo, Steven H Swerdlow

Abstract readReview
PubMed Publisher
In one paragraph

Review in Virchows Archiv : an international journal of pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. [Diagnostic challenges in pediatric lymphomas].Pathologie (Heidelberg, Germany) · 2026
    Review
  3. Review
  4. Review
  5. Pediatric lymphomas: overview and diagnostic challenges.Virchows Archiv : an international journal of pathology · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Follicular lymphoma and marginal zone lymphoma: how many diseases?Virchows Archiv : an international journal of pathology · 2023
    Review
  15. Article
  16. Pediatric-type follicular lymphoma: a short review.International journal of hematologic oncology · 2022
    Review
  17. Article
  18. Article
  19. [Large B-cell lymphoma with IRF4 rearrangement: six case reports and a literature review].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 6 countries.

Leticia Quintanilla-MartinezInstitute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Liebermeisterstrasse 8, 72076, Tübingen, Germany. Leticia.Quintanilla-Fend@med.uni-tuebingen.de.
Birgitta SanderDepartment of Laboratory Medicine, Division of Pathology, Karolinska Institut and Karolinska University Hospital Huddinge, Stockholm, Sweden.
John K C ChanQueen Elizabeth Hospital, Hong Kong, SAR, China.
Luc XerriDepartment of Bio-Pathology, Institut Paoli-Calmettes, Marseille, France.
German OttDepartment of Clinical Pathology, Robert-Bosch-Hospital and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
Elias CampoHospital Clinic, University of Barcelona, Barcelona, Spain.
Steven H SwerdlowDepartment of Pathology, Division of Hematopathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology · DEInstitut Paoli-Calmettes · FRKarolinska University Hospital · SEQueen Elizabeth Hospital · CNUniversitat de Barcelona · ESUniversity of Pittsburgh · USUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Indolent lymphomas in the pediatric population were discussed during the 2014 European Association for Haematopathology/Society of Hematopathology workshop in Istanbul, Turkey. This session was focused on pediatric-type follicular lymphoma (FL), and its differential diagnosis with the newly recognized entity of IRF4/MUM1+ lymphomas mainly involving Waldeyer's ring. The differential diagnosis between t(14;18) negative FL grade 1/2 and pediatric-type FL in adults was highlighted. The overlapping pathological and clinical features between FL and nodal marginal zone lymphoma (NMZL) in children and young adults were recognized and morphologic and immunophenotypical criteria helpful for the differential diagnosis were presented. Both pediatric-type FL and NMZL are indolent processes that should be distinguished from atypical lymphoid hyperplasia of the tonsils and lymph nodes. The demonstration of a B cell monoclonal population by molecular studies is strongly recommended for the diagnosis. Recognition of these indolent variants to avoid overtreatment was emphasized. Whereas most indolent lymphomas in the pediatric population show characteristic clinical, pathologic, and genetic features that differ from the adult counterpart, other rare indolent lymphoid tumors such as chronic lymphocytic leukemia (CLL) have similar characteristics. In this report, novel findings, areas of special interest, and diagnostic challenges emerging from the cases submitted to the workshop will be discussed.

Indexed as

AnimalsB-LymphocytesDiagnosis, DifferentialHumansLeukemia, Lymphocytic, Chronic, B-CellLymph NodesLymphoma, B-Cell, Marginal ZoneLymphoma, FollicularIndolent pediatric lymphomasIRF4/MUM1+ lymphomasPediatric nodal marginal zone lymphomaPediatric-type follicular lymphomaWaldeyer’s ring lymphomas

Identifiers

PMID26416032
OpenAlexW2208018442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.